نتائج البحث - "Stanley, R."

1

Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy

المصدر: Blood. 133:1652-1663

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, medicine.medical_specialty, medicine.medical_treatment, Antigens, CD19, Immunology, Hematopoietic stem cell transplantation, Immunotherapy, Adoptive, Biochemistry, Disease-Free Survival, Lymphocyte Depletion, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Refractory, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, hemic and lymphatic diseases, Internal medicine, Humans, Medicine, B cell, Salvage Therapy, Chemotherapy, Receptors, Chimeric Antigen, business.industry, Remission Induction, Hematopoietic Stem Cell Transplantation, Cell Biology, Hematology, Immunotherapy, Middle Aged, Chimeric antigen receptor, Fludarabine, 030104 developmental biology, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Female, Chimeric Antigen Receptor T-Cell Therapy, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41d7246327c3ca47495ee381fd060f65Test
https://doi.org/10.1182/blood-2018-11-883710Test

2

Chimeric antigen receptor–modified T cells: CD19 and the road beyond

المؤلفون: Stanley R. Riddell, Alexander I. Salter, Margot J. Pont

المصدر: Blood. 131:2621-2629

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95ec8dcc199e0392870e92ef928fe611Test
https://doi.org/10.1182/blood-2018-01-785840Test

3

Infectious complications of CD19-targeted chimeric antigen receptor–modified T-cell immunotherapy

المؤلفون: Michael Boeckh, Margaret L. Green, Stanley R. Riddell, Kevin A. Hay, David G. Maloney, Daniel Li, Sindhu Cherian, Xueyan Chen, Joshua A. Hill, Cameron J. Turtle

المصدر: Blood

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, medicine.medical_specialty, T-Lymphocytes, medicine.medical_treatment, Chronic lymphocytic leukemia, Immunology, Cell- and Tissue-Based Therapy, Receptors, Antigen, T-Cell, Infections, Severity of Illness Index, Biochemistry, Gastroenterology, Cohort Studies, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Antigen, Internal medicine, medicine, Humans, Aged, Chemotherapy, business.industry, Lymphoma, Non-Hodgkin, Cell Biology, Hematology, Immunotherapy, Middle Aged, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Prognosis, medicine.disease, Leukemia, Lymphocytic, Chronic, B-Cell, Chemotherapy regimen, United States, Chimeric antigen receptor, Cytokine release syndrome, Leukemia, 030104 developmental biology, 030220 oncology & carcinogenesis, Female, business, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78dedc35dae72eaee67283c13ebee4aaTest
https://doi.org/10.1182/blood-2017-07-793760Test

4

Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor–modified T-cell therapy

المؤلفون: W. Conrad Liles, Mark M. Wurfel, Xueyan Chen, Kevin A. Hay, David G. Maloney, Daniel Li, Dominic W. Chung, Cameron J. Turtle, Susanna Harju-Baker, Stanley R. Riddell, Junmei Chen, José A. López, Juliane Gust, Sindhu Cherian, Laila-Aicha Hanafi

المصدر: Blood. 130:2295-2306

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Immunobiology and Immunotherapy, T-Lymphocytes, medicine.medical_treatment, Immunotherapy, Adoptive, Biochemistry, 0302 clinical medicine, Risk Factors, Syndrome, Hematology, Blood Coagulation Disorders, Middle Aged, Fludarabine, Cytokine release syndrome, Treatment Outcome, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Cytokines, Female, Neurotoxicity Syndromes, Chimeric Antigen Receptor T-Cell Therapy, medicine.drug, Adult, medicine.medical_specialty, Fever, Cyclophosphamide, T cell, Immunology, Receptors, Antigen, T-Cell, Young Adult, 03 medical and health sciences, Internal medicine, Biomarkers, Tumor, otorhinolaryngologic diseases, medicine, Humans, Lymphocyte Count, Aged, Chemotherapy, business.industry, Hemodynamics, Endothelial Cells, Cell Biology, Immunotherapy, medicine.disease, Chimeric antigen receptor, Hematopoiesis, Kinetics, 030104 developmental biology, Multivariate Analysis, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f79fa342a699a6b99feb0efde0a0902dTest
https://doi.org/10.1182/blood-2017-06-793141Test

5

Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults

المؤلفون: Olivia Finney, Christopher Brown, Daniel Li, Catherine Lindgren, Rebecca Gardner, Julie R. Park, Hannah Brakke, Marie Bleakley, Virginia Hoglund, Stanley R. Riddell, Corinne Summers, Michael C. Jensen, Karen S. Kelly-Spratt, Assaf P. Oron, Colleen Annesley, Stephanie Mgebroff, Kasey J. Leger

المصدر: Blood. 129:3322-3331

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d7d85b58e894614d51af761bf042fdbTest
https://doi.org/10.1182/blood-2017-02-769208Test

6

The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells

المصدر: Blood. 133(17)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, medicine.medical_specialty, Cyclophosphamide, medicine.medical_treatment, Immunology, Antigens, CD19, Cell- and Tissue-Based Therapy, Receptors, Antigen, T-Cell, Aggressive Non-Hodgkin Lymphoma, Biochemistry, Lymphocyte Depletion, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Medicine, Humans, Survival rate, business.industry, Lymphoma, Non-Hodgkin, Cell Biology, Hematology, Immunotherapy, Middle Aged, medicine.disease, Prognosis, Combined Modality Therapy, Chimeric antigen receptor, Fludarabine, Lymphoma, Survival Rate, 030104 developmental biology, Cytokine, 030220 oncology & carcinogenesis, Female, business, Vidarabine, medicine.drug, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cdec1c711318f730b04388ec04c6587Test
https://pubmed.ncbi.nlm.nih.gov/31023743Test

7

Phase 1 studies of central memory–derived CD19 CAR T–cell therapy following autologous HSCT in patients with B-cell NHL

المصدر: Blood. 127:2980-2990

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Clinical Trials and Observations, T-Lymphocytes, medicine.medical_treatment, Cell Count, Hematopoietic stem cell transplantation, Immunotherapy, Adoptive, Biochemistry, 0302 clinical medicine, immune system diseases, hemic and lymphatic diseases, Lymphoma, Non-Hodgkin, Hematopoietic Stem Cell Transplantation, hemic and immune systems, Hematology, Middle Aged, Combined Modality Therapy, Cytokine release syndrome, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Female, Adult, medicine.medical_specialty, Lymphoma, B-Cell, Recombinant Fusion Proteins, Antigens, CD19, Immunology, Receptors, Antigen, T-Cell, chemical and pharmacologic phenomena, Transplantation, Autologous, Young Adult, 03 medical and health sciences, Internal medicine, medicine, Humans, B cell, Aged, business.industry, Cell Biology, Immunotherapy, medicine.disease, Chimeric antigen receptor, Lymphoma, Transplantation, 030104 developmental biology, business, Immunologic Memory, CD8

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::329746af5d8c52f5b63d4bc211e477e9Test
https://doi.org/10.1182/blood-2015-12-686725Test

8

Efficacy and Toxicity of JCAR014 in Combination with Durvalumab for the Treatment of Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

المصدر: Blood. 132:1680-1680

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::e596efa7b76bea5137ed2aea07e3ee1aTest
https://doi.org/10.1182/blood-2018-99-116745Test

9

Comparison of Efficacy and Toxicity of CD19-Specific Chimeric Antigen Receptor T-Cells Alone or in Combination with Ibrutinib for Relapsed and/or Refractory CLL

المصدر: Blood. 132:299-299

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::d0125cdece3eea884d4e1c161e874ad2Test
https://doi.org/10.1182/blood-2018-99-111061Test

10

Fully Human Bcma Targeted Chimeric Antigen Receptor T Cells Administered in a Defined Composition Demonstrate Potency at Low Doses in Advanced Stage High Risk Multiple Myeloma

المؤلفون: Pamela S. Becker, Margot J. Pont, Bruce Thompson, Frederick R. Appelbaum, Damian J. Green, Brian G. Till, David G. Coffey, Cameron J. Turtle, Andrew J. Cowan, Anne M Nagengast, Stanley R. Riddell, Michelle L Blake, Brent L. Wood, David G. Maloney, Ted Gooley, Melissa Works, Blythe D. Sather, Edward N. Libby, Sherilyn A. Tuazon

المصدر: Blood. 132:1011-1011

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::2dd6f55d9acd0ef0a5464eaa5d0301b7Test
https://doi.org/10.1182/blood-2018-99-117729Test

تنقيح النتائج